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Background: The increasing consumption of fruits and vegetables has contributed to the improvement of
populational health, due in part, to the abundance of antioxidants in these foods. Antioxidants reduce the level of
oxidative damage to DNA caused by free radicals and ionizing radiation, including the radioisotope iodine-131
(131I). This isotope is used for the diagnosis and treatment of thyroid injuries, such as hyperthyroidism and cancer.
Methods: This study aimed to evaluate the radioprotective and cytotoxic activity of acute and subchronic
treatments with Barbados Cherry (BC) (Malpighia glabra L.) fruit juice (5 mg), which is rich in potent antioxidants
such as vitamin C, phenols, carotenoids, anthocyanins and yellow flavonoids and its activity against the mutagenic
activity of the therapeutic dose of 25 μCi of radioiodine for hyperthyroidism. The test system used was the bone
marrow cells of Wistar rats (Rattus norvegicus) that were treated in vivo by gavage.
Results: BC showed radioprotective activity in acute treatments, which is most likely due to the joint action of its
antioxidant components. In subchronic treatments, the continuous treatment presented an effective radioprotective
activity, which was significantly different from treatment with the radiopharmaceutical only. Treatment with BC
prior to (PRE) and simultaneous with (SIM) ionizing radiation decreased the number of induced chromosomal
alterations, while post-treatment produced no protective effect. In addition, BC exhibited no cytotoxic activity.
Conclusions: These data serve as evidence that BC can be used as a preventive health measure to improve public
health quality by countering the action of inevitable exposure to mutagens, such as 131I.
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Iodine-131 (131I), a source of ionizing radiation, has been
used in nuclear medicine to evaluate the performance and
morphology of the thyroid gland and to treat thyroid can-
cer, metastases and hyperthyroidism [1]. Several studies
have confirmed the mutagenic activity of different doses of
131I based on evidence from the induction of micronuclei
[2,3] and the presence of chromosomal aberrations [4,5].
To combat the deleterious effects of free radicals, living
organisms have developed antioxidant defense systems.* Correspondence: lisdusman@yahoo.com.br
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reproduction in any medium, provided the orAntioxidants are substances that significantly reduce or
prevent the oxidation of a substrate [6]. This prevention is
achieved by sequestration of the free radicals generated by
cellular metabolism or exogenous sources, with the latter
being mainly produced from exposure to sources of radi-
ation such as the 131I radioisotope. Reduced oxidation
subsequently prevents attacks that occur on lipids, pro-
teins, amino acids and the double bonds of polyunsatur-
ated fatty acids and DNA bases, which, in turn, helps
prevent cellular injuries and loss of cellular integrity [7,8].
Antioxidant compounds can be incorporated due to
choices in diet, with fruits and vegetables providing es-
pecially large amounts of antioxidants [9]. For example,
the Barbados Cherry fruit (Malpighia glabra L.), which
is from the family Malpighiaceae that is native to Centrall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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vitamin C and nutrients such as vitamins A, B1 and B2;
carotenoids; anthocyanins; proteins; fats; carbohydrates;
and minerals [10-13].
Considering that radiotherapy can produce unwanted
side effects, it is important to find ways to minimize
such effects through the use of radioprotective sub-
stances or compounds. In particular, identifying natural
foods with radioprotective activity increases the possibil-
ity of antioxidant and nutraceutical consumption with-
out interfering with normal lifestyles. In this sense, this
study aimed to investigate the radioprotective activity of
in natura Barbados Cherry fruit pulp against in vivo




The Barbados Cherry fruit in natura was harvested just be-
fore use in the Medicinal Garden ‘Irenice Silva’ from the
State University of Maringá-Paraná-Brazil (UEM) (Exsiccate
HUEM 5657, lat: -23.4253 long: -51.9386 err: ±19250
WGS84). The plant juice was prepared in a blender, mixing
5 mg of fresh Barbados Cherry pulp/1 mL of water and was
administered by gavage in the volume of 1 mL of juice/
100 g of body weight (bw) of the animal to be tested.
This volume achieved a concentration that did not
cause an increase in the chromosomal damage in theFigure 1 Treatment times (acute, 24 hours; subchronic, 5–10 days)
Iodine-131 (131I).bone marrow cells of Wistar rats, as demonstrated in
previous research [14].
The radioisotope 131I was obtained from IPEN (Institute
of Energy and Nuclear Research-São Paulo-Brazil) and was
used at 25 μCi or 0.925 MBq/100 g bw by gavage. This
concentration is used for the treatment of hyperthyroidism
in humans and this concentration was demonstrated to
produce a great amount of chromosomal damage in the
bone marrow cells of Wistar rats in previous work [5].
The negative control (CO-) was prepared with 1 mL of
water/100 g bw by gavage.
Wistar rats
Six Wistar rats, three males and three females for each
group, were obtained from the Central Vivarium of the
State University of Maringá (UEM). Experiments were
carried out using 35-day-old rats weighing approxi-
mately 100 g.
The treatment and control groups used to determine
the antimutagenicity of the Barbados Cherry against
131I in acute and subchronic treatments are illustrated
in Figure 1.
The measurements of the radiation exposure rates of
each animal and the elimination of radiation via sweat,
urine and feces were conducted after the treatments
using a Geiger Muller counter, which was calibrated in
2008 and was positioned 3 cm away from the animal or
bed/wood shavings. The measurement started at 0 hours
after administration of 131I and was repeated every
4 hours for the first 12 hours, resulting in counts of 0, 4,of different groups treated with Barbados Cherry (BC) and
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sacrificed 24 hours after radiation administration and
counts of 0, 4, 8, 12, 24, 48, 72, 96 and 120 hours for
treatments with the animals being sacrificed 5 days after
radiation administration. To measure the radiation elim-
ination rate of animals via sweat, urine and feces, the
wood shavings placed in each box were initially weighed
(70 g) and changed whenever the radiation measure-
ments were performed.
Food (Nuvilab CR1, Paraná, Brazil) and water were
changed daily, but the animals were fasted for two hours
before and two hours after treatment, similar to the
method applied to humans in these types of treatments.
Water consumption was observed in all groups, every
4 hours for the first 12 hours and every 24 hours after
treatment and the animals were sacrificed 5 days after
radiation administration.
Ethics Statement
During the experimentation period, the animals remained
under controlled temperatures of approximately 25°C,
with humidity at approximately 50% and a photoperiod of
12 hours light/dark. Furthermore, all Ethical Principles,
Protocols and Regulations on Experimentation with
Laboratory Animals were used according to inter-
nationally established standards and with the approval
of the Institutional Ethics Committee of the State University
of Maringá (UEM) and the Ethics Committee on Animal
Use in Experimentation (CEAE)/UEM (process number:
PRO 027/2009). These experiments followed the Ethical
Principles for Animal Experimentation established by the
Brazilian College of Animal Experimentation (COBEA) as
well as the specific treatment and collections protocols for
the chromosomal aberration test.
Chromosomal aberration test
The chromosomal aberration test was performed on the
bone marrow cells of Wistar rats by the methodology of
Ford and Hamerton [15] with modifications. The cells
were interrupted in the mitotic metaphase with intraper-
itoneal administration of 0.5 mL/100 g bw of colchicine
(0.16%) (Acros Organics, New Jersey, USA) for one hour
and 30 minutes before euthanasia. For euthanasia,
0.5 mL thionembutal (1 g of sodium thiopental/25 mL
of distilled water) (Abbott Labs. do Brasil Ltda, São
Paulo, Brazil) was administered intraperitoneally.
Bone marrow was removed from the femurs with 5 mL of
hypotonic solution (0.075 M potassium chloride - Labsinth,
São Paulo, Brazil). The suspension was left at 37°C for 12 mi-
nutes (403/3 N incubator, São Paulo, Brazil), centrifuged for
5 minutes (Excelsa 3 centrifuge, São Paulo, Brazil), and the
supernatant was discarded. The remaining material was
fixed with 5 mL of a 3:1 methanol: acetic acid solution
(Merck, Germany) and centrifuged for 5 minutes. Thesupernatant was discarded, and the fixative was chan-
ged at least twice. Slides were prepared with a drop of
suspension on clean slides containing a film of distilled
water ice. Slide coloration was performed using a drop
from a film of Giemsa solution (Merk, Germany) in
0.06 M phosphate buffer (Na2HPO4, Labsinth, São Paulo,
Brazil), 12 mL H20 and 0.06 M KH2PO4 (Vetec Química,
Rio de Janeiro, Brazil) at a ratio of 1:30 at pH 6.8.
Slide analysis was performed in a “blind test” with a
light microscope (Olympus KHC, Brazil) for 100 meta-
phases per animal, totaling 600 for each of the treatment
and control groups. Samples were assessed for the ap-
pearance of alterations such as gaps, breaks and other
fragments. The average percentage of chromosomal ab-
errations (CA) was calculated by dividing the total num-
ber of alterations found, including gaps, by the total
number of cells in metaphase that were analyzed for
each treatment and control group.
The mitotic index (MI) for the cytotoxicity evaluation
was calculated from 5,000 cells by sex, resulting in a
total of 10,000 cells per control and treatment group.
The MI calculation as a percentage was determined by
dividing the number of dividing cells by the total num-
ber of cells in the field.
Statistical calculations were performed using Student’s
t test (n = 6, α < 0.05).
Physical-chemical analysis
Extracts of barbados cherry
The Barbados Cherries were washed with running pot-
able water in abundance, and the edible part, pulp and
rind were separated manually. The pulp was disinte-
grated manually, frozen in a domestic freezer and pro-
tected from light for later analysis.
Treatments were prepared with four different extracts
of Barbados Cherry pulp and were performed with the
addition of water for dilution. The 50% methanol/70%
acetone extract was prepared according to the method-
ology described by Rufino et al. [16]. Extract containing
80% ethanol and 1% 1.5 N HCl was prepared following
the methodology described by Lima et al. [17]. In addition
to these extracts, aqueous extracts were made similar to
that used in in vivo tests, and 80% methanol and 80% acet-
one extracts were prepared using the solvent extractor
with 2.0 g pulp with agitation in the dark for 60 minutes.
Determination of total phenols
The total phenol content of the five extracts was deter-
mined using the Folin-Ciocalteu reagent and a stand-
ard curve of gallic acid as a reference according to the
methodology described by Wettasinghe and Shahidi
[18]. The total phenol content was expressed as mg
gallic acid/100 g of pulp. The statistical calculation was
performed by the Tukey test (α = 0.05).
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The antioxidant activity of five extracts obtained from the
pulp of Barbados Cherries was measured by determining
their capacity to scavenge 1,1-diphenyl-2-picrylhydrazyl
(DPPH) radicals according to the method described by
Brand-Williams et al. [19] and modified by Miliauskas et al.
[20]. The absorbance was read at 515 nm 15, 30 and 45 mi-
nutes after initiating the reaction with DPPH solution.
BHT (2,6-di-tert-butyl-4-methylphenol) (2,500 μg/mL) and
ascorbic acid (2,500 μg/mL) were used as reference sub-
stances for free radical scavenging activity (positive control).
Antioxidant activity, expressed as a percentage, was calcu-
lated in relation to the control according to the expression
below:
AA% = (Acontrol - Asample) ×100/(Acontrol).
The statistical calculation was performed by the Tukey
test (α = 0.05).
Determination of ascorbic acid
For the determination of the ascorbic acid content, the
methodology described by Horwitz [21] and modified by
Benassi and Antunes [22] was used. The pulp solution
was extracted with 2% oxalic acid and titraded with
0.01% 2,6-dichlorophenolindophenol to obtain a clear
pink color. The results were expressed as mg of ascorbic
acid/100 g of sample.
Determination of total carotenoids
The determination of total carotenoids was performed
according to the methodology described by Higby [23]
in which the Barbados Cherry pulp was extracted with
3:1 isopropyl alcohol: hexane. The absorbance was read
at 450 nm, and the results were expressed as mg/100 g
pulp, as calculated using the following formula:
Total carotenoids = (A450 × 100)/(250 × E × W), where
A = absorbance, E = cuvette width in cm, and W = the
quotient between the mass of the original sample in g
and the final volume of dilution in mL.
Determination of total anthocyanins and yellow flavonoids
The determination of total anthocyanins followed the
method of Francis [24]. The extracting solution used was
95% ethanol + 1.5 N HCl (85:15), and readings were taken
at 535 nm absorbance for anthocyanins and 374 nm for the
yellow flavonoids. The results were expressed as mg/100 g
pulp, as calculated using the following formulae:
Total anthocyanins = dilution factor × absorbance/98.2
Yellow flavonoids = dilution factor × absorbance/76.6
Results and discussion
Complementary and alternative therapies, such as the
consumption of antioxidants such as vitamins A, C, andE and β-carotene, can be used to reduce the toxicity of
radiotherapy and increase the effectiveness of this pro-
cedure [25]. In this sense, there are many studies related
to the radioprotective capacity of chemical agents with
different characteristics, and special attention has been
focused on substances in the human diet because inges-
tion is a simple route of administration [26].
In this study, in natura Barbados Cherry fruit pulp,
which is a powerful antioxidant that inhibited approxi-
mately 99% of DPPH radicals (Table 1), significantly de-
creased the percentage of chromosomal abnormalities
caused by 131I (4.3 ± 2.8) in acute radioprotective treat-
ments (SIM - 1.2 ± 0.9, PRE - 1.3 ± 1.0 and POST - 1.2 ± 1.1)
(Figure 2A). Abnormalities decreased by approximately
72% (simultaneous treatment and post-treatment) and
70% (pre-treatment). These percentages were as high
and higher than those found by Almeida [27], wherein
in natura Barbados Cherry juice reduced the average
number of micronuclei induced by 131I in Rattus
norvegicus hepatoma cells by 50%. Vitamin C, a major
antioxidant component of the Barbados Cherry (1960.02 ±
2.32 mg/100 g of sample – Table 2), was assessed by Narra
et al. [28] at a concentration of 1.5 μg and showed a ra-
dioprotective effect when administered 4 hours before
a 131I radioisotope dose of 0.85 μCi (pre-treatment) in
mouse spermatocytes.
Positive results for the Barbados Cherry fruit radiopro-
tection may be partly due to the fruit’s mixture of anti-
oxidant compounds, such as vitamins A, B1, B2 and C;
carotenes; anthocyanins; phenols; and flavonoids, as
shown in the physical-chemical analysis data in Tables 1
and 2. Nunes et al. [29,30] also confirmed the protective
effect of the Barbados Cherry against the mutagen
hydrogen peroxide. These authors claim that the pro-
tective effect exerted by the fruit may be associated with
vitamin C and this complex mixture of nutrients, which
can interact with DNA and protect it against oxidative
stress. These compounds can confer better protection
against the damage caused by free radical formation in
comparison to conditions in which no antioxidants are
present, thus preventing mutations resulting in genetic
and chromosomal alterations, as discussed by Prasad
et al. [31] and Getoff [32]. This claim is further corrobo-
rated by data from Wakabayashi et al. [33] and Hanamura
et al. [34], which showed that the Barbados Cherry and its
constituents, such as anthocyanins, possess the ability to
capture free radicals.
According to Prasad et al. [35], antioxidants adminis-
tered before or after ionizing radiation, similar to the
pre- and post-treatments performed in this study, in-
crease the effect of radiation on cancer cells, protect
normal cells from damage and reduce the harm arising
from this radiation. Supported by these previous results,
Barbados Cherry fruit juice may have acted in acute
Figure 2 Percentage and standard deviation of mitotic index and chromosomal aberration of different antimutagenic treatments in
acute (A - 24 hours) and subchronic (B - 5 days) groups. Groups: Negative control: CO-; Barbados Cherry: BC (Results published in [14]);
Iodine-131: 131I (Results published in [5]). Antimutagenic Treatments: SIM: simultaneous; PRE: pre-treatment; POST: post-treatment; CON:
continuous. * Statistically significant result compared with negative control (p < 0.01). # Statistically significant result compared with treatment
with 131I (p < 0.04). § Statistically significant result compared with treatment with BC (p < 0.02).
Table 1 Total phenols values and antioxidant activity from Barbados Cherry pulp extracts
Extracts Total Phenols % Inhibition of DPPH Radical
15 min 30 min 45 min
50% Methanol/ 4,478.37 ± 361.36a 98.89 ± 0.53a 98.64 ± 0.54 98.44 ± 0.38
70% Acetone
80% Ethanol/HCl 4,683.08 ± 216.49a 93.31 ± 0.17ab 95.63 ± 0.00ab 96.18 ± 0.09b
Water 4,631.70 ± 55.00a 97.29 ± 0.453bc 97.34 ± 0.53c 97.34 ± 0.53
80% Methanol 6,142.65 ± 15.80 97.44 ± 0.66 97.29 ± 0.90 97.29 ± 0.90
80% Acetone 4,807.84 ± 102.58a 98.44 ± 0.44c 98.44 ± 0.44c 98.44 ± 0.44c
BHT 2,500 μg/mL - 96.03 ± 0.53abcd 96.18 ± 0.38bd 96.23 ± 0.45bd
Ascorbic Acid - 98.44 ± 0.53c 98.49 ± 0.45c 98.54 ± 0.53c
2,500 μg/mL
n = 3, Total Phenols = mg Gallic Acid/100 g of pulp.
aStatistically significant result compared with the 80% methanol extract (p < 0.05).
bStatistically significant result compared with the 50% methanol extract/70% acetone extract (p < 0.05).
cStatistically significant result compared with the 80% ethanol extract/HCl (p < 0.001).
dStatistically significant result compared with the 80% acetone extract (p < 0.001).
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Table 2 Ascorbic acid, total carotenoid, total anthocyanin and yellow flavonoid values from Barbados Cherry pulp
extracts
Ascorbic Acid (mg/100 g
of sample)
Total Carotenoids (mg/100 g
of sample)
Total Anthocyanins (mg/100 g
of sample)
Yellow Flavonoids (mg/100 g
of sample)
1,960.02 ± 2.32 0.615 ± 0.005 8.09 ± 0.09 11.03 ± 0.13
n = 3.
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active oxygen to protect cells by neutralizing free radi-
cals in the pre-treatment and simultaneous treatment
groups, while potentially acting in the healing process of
injuries caused by ionizing radiation in the post-treatment
group.
Moreover, the treatments conducted in this study showed
no cytotoxic effect of the radioprotective acute treatments
on the bone marrow cells of Wistar rats (Figure 2A) be-
cause the mitotic index of these groups (SIM - 2.0 ± 0.5,
PRE - 2.2 ± 0.4, POST - 2.1 ± 0.2) was similar to that of the
negative control (1.4 ± 0.8). Almeida et al. [27] also ob-
served the absence of cytotoxic effects of Barbados Cherry
treatments for 24 hours alone or together with 131I by the
micronucleus test with in vitro hepatoma cells of Rattus
norvegicus. Similarly, negative results for the cytotoxicity of
this fruit were found by Düsman et al. [14] by a chromo-
some aberration test with bone marrow cells of rats in vivo.
Moreover, Nefic [36] observed that vitamin C (10 and
100 μg/mL), which is the major antioxidant constituent of
the fruit, did not alter the mitotic index of treated human
peripheral lymphocytes.
Furthermore, all mitotic index percentages of the radio-
protective subchronic treatments (SIM - 1.5 ± 0.3, PRE -
1.9 ± 0.5, POST - 1.7 ± 0.4, CON - 1.6 ± 0.5) (Figure 2B)
were statistically similar to the mitotic index percent-
age of the negative control (1.4 ± 0.2), proving the non-
cytotoxicity of these groups in this test system. When
treated alone, the Barbados Cherry fruit presented a
mitotic index percentage (2.2 ± 0.4) greater than and
significantly different from the negative control (1.4 ± 0.2).
This increase in cell division most likely occurred due to
the chemical composition of the fruit, particularly the
relevant vitamins and sugars that stimulated cell div-
ision in normal cells from the bone marrow of treated
rats. According to Hosseinimehr [6], radioprotective
agents that can affect haematopoietic stem cell regen-
eration have attracted significant interest because these
compounds can increase survival rates by stimulating
the function and regeneration of the stem cell popula-
tion that is decreased by radiation-induced damage.
Thus, despite the fact that the Barbados Cherry juice
stimulated cell division of the bone marrow, the radio-
protective groups (SIM, PRE, POST and CON) treated
with fruit and 131I showed percentages of the mitotic
index that were significantly lower than the group
treated only with Barbados Cherry.With regard to the percentage of chromosomal ab-
normalities in radioprotective subchronic treatments
(Figure 2B), the simultaneous (1.2 ± 1.1) and pre-treatment
(1.3 ± 0.5) groups were not significantly different from 131I
treatment (2.2 ± 1.1), but showed an effective decrease in
the percentage of chromosomal abnormalities, specifically,
41% for the pre-treatment condition and 45% for the
simultaneous treatment condition. The POST-subchronic
treatment presented a percentage of chromosomal abnor-
malities (2.2 ± 0.7) similar to the treatment using 131I but
significantly different from the negative control (0.5 ± 0.8).
Only the continuous treatment group (0.7 ± 0.8) showed
significantly different values from the treatment per-
formed only with 131I, decreasing the percentage of
chromosomal abnormalities induced by 131I by 68%.
Continuous subchronic BC treatment produced the low-
est percentage of chromosomal abnormalities (0.7 ± 0.8)
among all treatments performed in this study (SIM, PRE
and POST). This was also the group that received more
doses of Barbados Cherry fruit (for 10 consecutive days),
compared to simultaneous group (1 day), pre-treatment
(5 days) and post-treatment (4 days), which may have re-
sulted in this effect protective more effective. Thus,
daily and continuous consumption of fruit, including
the Barbados Cherry and other antioxidant-rich mix-
tures, seems to be the best alternative for preventing
and combating mutations caused by ionizing radiation.
These data agree with the work of Blumenthal et al.
[37], who reported that the combination of vitamins E,
C and A, when administered to mice for 14 days (three
days before and 11 days after radiation), also reduced
the toxicity of radioimmunotherapy with 131I (400 μCi),
which are similar to the results obtained for the continu-
ous treatment group in this study (11 days total, 5 days be-
fore, 1 day with, and 4 days after radiation). The findings
of Narra et al. [28] also confirm these data, as they showed
that vitamin C administered in continuous treatments
(5 days pre-treatment and 7 days post-treatment) resulted
in radioprotective effects against 131I.
The present study indicates that subchronic treatment
with the Barbados Cherry confers higher radioprotective
activity in the capture of free radicals or the prevention
of their formation - as demonstrated by results from the
pre-treatment, simultaneous treatment and continuous
treatment groups [38]. These data demonstrate that dif-
ferent types of subchronic treatments interfere with the
radioprotective effect of fruit because despite having
Figure 3 Rate of exposure and elimination of Iodine-131 (25 μCi) from Wistar rats exposed to different antimutagenic treatments that
were sacrificed at 24 hours (A) and 5 days (B) after radiation administration. Groups: Iodine-131: 131I (Results published in [5]). Antimutagenic
Treatments: SIM: simultaneous; PRE: pre-treatment; POST: post-treatment; CON: continuous.
Figure 4 Water consumption by animals exposed to different antimutagenic treatments that were sacrificed 24 hours or 5 days after
the administration of 131I. Groups: Negative control: CO-; Iodine-131: 131I (Results published in [5]). Antimutagenic Treatments: SIM: simultaneous;
PRE: pre-treatment; POST: post-treatment; CON: continuous. * Statistically significant result compared with 24-hour negative control (p < 0.001). # Statistically
significant result compared with 5 days negative control (p < 0.01). £ Statistically significant result compared with treatment with 131I and sacrifice after
5 days (p < 0.001).
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treatment reduced by almost half (45%) of chromosomal
abnormalities generated by I-131, and post-treatment,
which received 4 doses of fruit did not affect the per-
centage of chromosomal alterations induced by I-131.
Moreover, the Barbados Cherry does not induce a syner-
gistic effect with 131I because when these two compounds
were administered together in the post-subchronic treat-
ment, there was no increase in the percentage of chromo-
somal abnormalities in this group (2.2 ± 1.1) compared to
that found in the treatment with 131I alone (2.2 ± 0.7). It
is interesting that in this study there were no significant
differences between male and female rats in the percent-
age of chromosomal alterations and mitotic indices.
In the present study, the elimination of 131I (Figure 3)
as measured in the bed/wood shavings of the cage, was
not modified by the intake of Barbados Cherry because
the acute radioprotective treatments produced a 24-hour
elimination percentage similar to 131I alone (131I = 84%,
SIM, PRE and POST = 89%). Subchronic radioprotective
treatments produced elimination percentages in the range
of 74-86% (131I = 86%, SIM and PRE = 74%, POST and
CON= 77%), which is better than expected according to
the observations of Reiners and Labmann [39], which
were 40-70%.
However, the rate of radiation exposure within rats
was higher with ingestion of the Barbados Cherry in the
radioprotective acute treatments (4 hours) and sub-
chronic treatments (from 4 to 24 hours) compared to
treatments performed only with 131I. This increased
rate of radiation exposure did not interfere with the ra-
dioprotective activity of the Barbados Cherry, which can
be explained by rates of radiation elimination, which in-
creased during the 8 hours of radioprotective acute
treatments and by the maintenance of a higher variable
level in the radioprotective subchronic treatments from
4 to 24 hours, peaking at 24 hours. The highest radiation
elimination rate, which was measured within 24 hours of
the radioprotective subchronic treatment, compared with
the same period of acute treatment, may be associated
with the increased water consumption (Figure 4) observed
in animals subjected to these treatments (PRE, SIM, POST
and CON). Water consumption by the continuous treat-
ment group was significantly different than both the
negative control and the 131I treatment groups. This
information also suggests that any ingestion of radio-
isotopes alters the metabolism of animals, leading to
greater intake of water to continuous treatment.
Conclusions
Because ionizing radiation induces chromosomal and cel-
lular aberrations by the production of free radicals that
affect DNA, it is important to certify agents that are able
to prevent this oxidative stress and the production ofmutations. Thus, the results of this study emphasize that
consumption of Barbados cherries showed antimutagenic
effects against radioisotope 131I in acute and subchronic
treatments, mainly by acting in the capture of free radicals
produced by radiation. Therefore, the Barbados Cherry
fruit, which has antioxidant and radioprotective potential
as demonstrated in this study, has an important role in
preventive medicine prior, during and after mutagen ex-
posure, particularly for individuals who are exposed to ra-
diation from the radioisotope iodine-131I in diagnoses
and treatments.
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